Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma

Argininosuccinate synthetase 1 (ASS1), the rate-limiting enzyme for arginine biosynthesis, is expressed in many types of human malignancies. Recent studies showed that ASS1 may have tumor suppressor function and that ASS1 deficiency is associated with clinical aggressiveness in nasopharyngeal carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qingqing, Stewart, John, Wang, Hua, Rashid, Asif, Zhao, Jun, Katz, Matthew H., Lee, Jeffrey E., Fleming, Jason B., Maitra, Anirban, Wolff, Robert A., Varadhachary, Gauri R., Krishnan, Sunil, Wang, Huamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302782/
https://www.ncbi.nlm.nih.gov/pubmed/28187218
http://dx.doi.org/10.1371/journal.pone.0171985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302782/
https://www.ncbi.nlm.nih.gov/pubmed/28187218
http://dx.doi.org/10.1371/journal.pone.0171985

Ejemplares similares